📰 Approval Program News
Page 54 - Approval Program News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Approval Program. Real-time updates on events, politics, business and more.
September 27, 2023
The University of Southern Indiana Pott College of Science, Engineering, and Education has received a five-year extension on its accreditation for its Chemistry and Biochemistry programs from the American Chemical Society (ACS). The ACS Approval Program promotes excellence in chemistry education
August 21, 2023
Pfizer Inc. (NYSE:PFE) today announced the U.S. Food and Drug Administration (FDA) has granted accelerated approval to ELREXFIO™ (elranatamab-bcmm) for the treatment of adult patients with relapsed or refractory multiple myeloma (RRMM) who have recei
August 14, 2023
The approval of ELREXFIO is based on clinically meaningful response rates and duration of response from Phase 2 MagnetisMM-3 study ELREXFIO is the first off-the-shelf fixed-dose subcutaneous... -Today at 02:09 pm- MarketScreener
August 9, 2023
The FDA’s accelerated-approval process was designed to help people access life-saving drugs. But gaps in communication could mean that people are undergoing treatments known to be ineffective. The FDA’s accelerated-approval process was designed to help people access life-saving drugs. But gaps in communication could mean that people are undergoing treatments known to be ineffective.
June 20, 2023
The shipbuilding industry is driving change at a pace to embrace digitalization. However, with increasing pressure to reduce costs, improve efficiency...
June 9, 2023
We are pleased to present the first issue of our newsletter analyzing recent trends and developments impacting the life sciences industry, including DOJ policy updates and key...
June 6, 2023
/PRNewswire/ -- Intensity Therapeutics, Inc. ("Intensity"), a clinical-stage biotechnology company focused on the discovery and development of proprietary,...
April 26, 2023
There has been a reduction in the number of drug approvals, and the process has slowed down to a great extent.
April 26, 2023
The U.S. Food and Drug Administration (FDA) has approved a drug for treating patients with a rare form of a neurological disease called amyotrophic lateral sclerosis (ALS).
April 25, 2023
Blood-based measurement of neurofilament light chain provides compelling evidence to support an accelerated drug approval by the FDA. The decision has positive implications for NfL blood testing as... | June 18, 2023